niacinamide has been researched along with Nephrotic Syndrome in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of nephrotic syndrome (NS) induced by both sunitinib and sorafenib therapy." | 7.78 | Sunitinib- and sorafenib-induced nephrotic syndrome in a patient with gastrointestinal stromal tumor. ( Benekli, M; Buyukberber, S; Cetin, B; Guz, G; Inal, S; Memis, L; Ozturk, SC; Turan, N, 2012) |
| " Shortly after chemotherapy with sorafenib [anti-vascular endothelial growth factor (VEGF)] was initiated, progressive renal impairment, hypertension, and nephrotic-range proteinuria developed." | 7.75 | Nephrotic-range proteinuria in a patient with a renal allograft treated with sorafenib for metastatic renal-cell carcinoma. ( Jonkers, IJAM; van Buren, M, 2009) |
| "To report a case of nephrotic syndrome (NS) induced by both sunitinib and sorafenib therapy." | 3.78 | Sunitinib- and sorafenib-induced nephrotic syndrome in a patient with gastrointestinal stromal tumor. ( Benekli, M; Buyukberber, S; Cetin, B; Guz, G; Inal, S; Memis, L; Ozturk, SC; Turan, N, 2012) |
| " Shortly after chemotherapy with sorafenib [anti-vascular endothelial growth factor (VEGF)] was initiated, progressive renal impairment, hypertension, and nephrotic-range proteinuria developed." | 3.75 | Nephrotic-range proteinuria in a patient with a renal allograft treated with sorafenib for metastatic renal-cell carcinoma. ( Jonkers, IJAM; van Buren, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yılmaz, S | 1 |
| Özçakar, ZB | 1 |
| Taktak, A | 1 |
| Kiremitçi, S | 1 |
| Ensari, A | 1 |
| Dinçaslan, H | 1 |
| Yalçınkaya, F | 1 |
| Jonkers, IJAM | 1 |
| van Buren, M | 1 |
| Overkleeft, EN | 1 |
| Goldschmeding, R | 1 |
| van Reekum, F | 1 |
| Voest, EE | 1 |
| Verheul, HM | 1 |
| Turan, N | 1 |
| Benekli, M | 1 |
| Ozturk, SC | 1 |
| Inal, S | 1 |
| Memis, L | 1 |
| Guz, G | 1 |
| Cetin, B | 1 |
| Buyukberber, S | 1 |
4 other studies available for niacinamide and Nephrotic Syndrome
| Article | Year |
|---|---|
Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Topics: Adolescent; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pro | 2016 |
Nephrotic-range proteinuria in a patient with a renal allograft treated with sorafenib for metastatic renal-cell carcinoma.
Topics: Angiogenesis Inhibitors; Antihypertensive Agents; Benzenesulfonates; Biopsy; Carcinoma, Renal Cell; | 2009 |
Nephrotic syndrome caused by the angiogenesis inhibitor sorafenib.
Topics: Angiogenesis Inhibitors; Benzenesulfonates; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms | 2010 |
Sunitinib- and sorafenib-induced nephrotic syndrome in a patient with gastrointestinal stromal tumor.
Topics: Angiogenesis Inhibitors; Benzenesulfonates; Female; Gastrointestinal Neoplasms; Gastrointestinal Str | 2012 |